Keywords: ucb, mulls, getting, out, chemicals, after, bid
UCB mulls getting out of chemicals, after bid for Celltech
Article | 31 May 2004
Belgian pharmaceutical and chemicals group UCB, which recently made an agreed $2.7 billion bid for UK biotechnology firm Celltech (Marketletter May 24), ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
